跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 29 条关于
“Tafinlar + Mekinist”
全部
29
临床试验
8
药物
2
机构
0
资讯
19
4年前
FDA Approves Novartis' Tafinlar + Mekinist Combo for BRAF V600E-Mutated Solid Tumors
去年
Meta-Analysis Confirms Tafinlar-Mekinist Combination's Efficacy Across Age Groups in Glioma Treatment
去年
Tafinlar and Mekinist Show Long-Term Mortality Reduction in Stage III Melanoma
2个月前
Novartis Q2 Earnings: Cosentyx and Kisqali Drive Growth Amid Entresto Decline and Generic Pressures
4年前
FDA Grants Accelerated Approval to Dabrafenib and Trametinib Combination for BRAF V600E-Mutated Solid Tumors
去年
Precision Medicine Approach Shows Promise in Anaplastic Thyroid Cancer
去年
Pharmac to Fund Advanced Melanoma Treatments in New Zealand Starting June 2025
去年
GSK and Novartis Complete $16 Billion Asset Swap Deal, Reshaping Both Companies' Strategic Focus
上个月
Russia's First Trametinib Generic Hits Market as Promomed Challenges Novartis' Mekinist
5个月前
ASCO Expands TAPUR Study with First Antibody-Drug Conjugate and BRAF/MEK Inhibitor Combination
第 1 页,共 2 页
上一页
下一页